[Alfadil and heart failure--clinical conclusions do exist!].
Lohm
Leif
L
Pfizer AB, Täby. leif.lohm@pfizer.com
Lindh
Erik
E
Frösing
Roland
R
D000924:Anticholesteremic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D017292:Doxazosin / Q000009:adverse effects / Q000627:therapeutic use*; D004346:Drug Information Services; D006333:Heart Failure / Q000139:chemically induced / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D008297:Male; D017410:Practice Guidelines as Topic; D011470:Prostatic Hyperplasia / Q000150:complications / Q000188:drug therapy
D000924:Anticholesteremic Agents; D000959:Antihypertensive Agents; D017292:Doxazosin